TITLE

Aberrant anatomy

AUTHOR(S)
Murray-Smith, Sean
PUB. DATE
August 1991
SOURCE
New Scientist;8/3/91, Vol. 131 Issue 1780, p51
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Comments on an article on the treatment of heart failure.
ACCESSION #
10556068

 

Related Articles

  • Letter to the Editor. da Cruz, Eduardo; Aggoun, Yacine; Tissot, C├ęcile; Beghetti, Maurice // Cardiology in the Young;Apr2007, Vol. 17 Issue 2, p234 

    A letter to the editor is presented in response to an article about the benefits of cardiac resynchronization in children with myocardial dysfunction.

  • NICE guidance on heart failure should not be lightly dismissed. Dillon, Andrew // Pulse;10/27/2003, Vol. 63 Issue 43, p27 

    Presents a letter to the editor referencing an article in the September 15, 2003 issue of 'Pulse,' about the role of angiotensin 2 antagonists for the treatment of heart failure.

  • Irbesartan for Heart Failure with Preserved Ejection Fraction. Amato, James L. // New England Journal of Medicine;3/19/2009, Vol. 360 Issue 12, p1256 

    A letter to the editor is presented in response to the article "Irbesartan in Patients With Heart Failure and Preserved Ejection Fraction," by B.M. Massie, P.E. Carson, J.J. McMurray, et al, published in the December 4, 2008 issue.

  • Irbesartan for Heart Failure with Preserved Ejection Fraction. Ghali, Jalal K. // New England Journal of Medicine;3/19/2009, Vol. 360 Issue 12, p1256 

    A letter to the editor is presented in response to the article "Irbesartan in Patients With Heart Failure and Preserved Ejection Fraction," by B.M. Massie, P.E. Carson, J.J. McMurray, et al, published in the December 4, 2008 issue.

  • Irbesartan for Heart Failure with Preserved Ejection Fraction. Tomoda, Haruo // New England Journal of Medicine;3/19/2009, Vol. 360 Issue 12, p1256 

    A letter to the editor is presented in response to the article "Irbesartan in Patients With Heart Failure and Preserved Ejection Fraction," by B.M. Massie, P.E. Carson, J.J. McMurray, et al, published in the December 4, 2008 issue.

  • Irbesartan for Heart Failure with Preserved Ejection Fraction. Schillaci, Giuseppe; Pucci, Giacomo; Pirro, Matteo // New England Journal of Medicine;3/19/2009, Vol. 360 Issue 12, p1256 

    A letter to the editor is presented in response to the article "Irbesartan in Patients With Heart Failure and Preserved Ejection Fraction," by B.M. Massie, P.E. Carson, J.J. McMurray, et al, published in the December 4, 2008 issue.

  • Irbesartan for Heart Failure with Preserved Ejection Fraction. Massie, Barry M.; Carson, Peter E. // New England Journal of Medicine;3/19/2009, Vol. 360 Issue 12, p1256 

    The authors reply to letters written in response to the article "Irbesartan in Patients With Heart Failure and Preserved Ejection Fraction," published in the December 4, 2008 issue.

  • Reversal of Pacing-Induced Heart Failure by Left Ventricular Apical Pacing. Vanagt, Ward Y.; Prinzen, Frits W.; Delhaas, Tammo // New England Journal of Medicine;12/20/2007, Vol. 357 Issue 25, p2637 

    Ward Y. Vanagt, Fritz W. Prinzen and Tammo Delhaas respond to a letter about their article "The Left Ventricular Apex is the Optimal Site For Pediatric Pacing: Correlation With Animal Experience" in an earlier issue.

  • Defibrillators in Heart Failure and Quality of Life. Matlock, Dan D. // New England Journal of Medicine;1/8/2009, Vol. 360 Issue 2, p187 

    A letter to the editor is presented in response to the article "Quality of Life With Defibrillator Therapy or Amiodarone in Heart Failure," by D.B. Mark, K.J. Anstrom, J.L. Sun, et al. in the September 4, 2008 issue.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics